Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cielo vs Dr. Gillis' Wellness Center

Cielo
Graded #127

Higher grade

vs+2.4000000000000057
Dr. Gillis' Wellness Center
Graded #177

Lower grade

The verdict

Cielo takes it — 69.4/100 to 67/100.

Cielo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cielo is a compounded-GLP-1-only telehealth platform offering semaglutide and tirzepatide with no brand-name drugs and no TRT, hair, or mental-health add-ons — a focused, single-purpose alternative to…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCielo +12
76
64
Dose & formulationCielo +17
85
68
Clinical oversightDr. Gillis' Wellness Center +5
79
84
Labs & monitoringEven
53
53
FulfillmentDr. Gillis' Wellness Center +14
67
81
Contract termsDr. Gillis' Wellness Center +17
20
37
Cielo · left barDr. Gillis' Wellness Center · right bar

The numbers

MetricCieloDr. Gillis' Wellness Center
WeighScore69.4/10067/100
GradeCC
Scorecard rank#127#177
Semaglutide$149/mo (all doses, compounded)$149/mo (starting dose, compounded)
Tirzepatide$249/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Cielo

Graded #127 · C

Strengths

  • Among the lowest 3-month bundle prices in compounded GLP-1 ($115/mo semaglutide)
  • Single flat price across all doses simplifies titration planning
  • Corporate address (St. Petersburg, FL) and customer-service phone published

Where it loses points

  • No LegitScript, NABP .pharmacy, or HIPAA badge on the home page
  • Pharmacy partner not named (only 'regulated FDA pharmacy partners')
  • State coverage list not published — can't verify all-50-state availability
  • Clinical care runs through MD Integrations, a shared third-party network used by many brands
  • No brand-name Wegovy or Zepbound option

Strengths

  • Sublingual ODT tablets offered as needle-free alternative
  • Broad GLP-1 menu: semaglutide, tirzepatide, and retatrutide
  • Transparent pricing: $150 starting dose, plans from $149/mo
  • Led by board-certified physician/surgeon with 25+ years experience
  • No contracts; flexible weekly, bi-weekly, or monthly cadence

Where it loses points

  • Specific dose-tier pricing beyond starting plan not detailed
  • Compounded vs brand not explicitly stated for all meds
  • Smaller clinic vs national telehealth brands
  • State licensing list not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard